Culture

New research on Alzheimer's Disease shows 'lifestyle origin at least in some degree'

For years, research to pin down the underlying cause of Alzheimer's Disease has been focused on plaque found to be building up in the brain in AD patients. But treatments targeted at breaking down that buildup have been ineffective in restoring cognitive function, suggesting that the buildup may be a side effect of AD and not the cause itself.

A new study led by a team of Brigham Young University researchers finds novel cellular-level support for an alternate theory that is growing in strength: Alzheimer's could actually be a result of metabolic dysfunction in the brain. In other words, there is growing evidence that diet and lifestyle are at the heart of Alzheimer's Disease.

"Alzheimer's Disease is increasingly being referred to as insulin resistance of the brain or Type 3 Diabetes," said senior study author Benjamin Bikman, a professor of physiology and developmental biology at BYU. "Our research shows there is likely a lifestyle origin to the disease, at least to some degree."

For the new study, published in academic journal Alzheimer's & Dementia, the BYU research team examined RNA sequences in 240 post-mortem Alzheimer's Disease-impacted brains. They were looking specifically at the gene expression of nervous system support cells during two types of metabolism: glucose metabolism, where carbohydrates are broken down to provide energy, and something called ketolytic metabolism.

Ketolytic metabolism involves the brain creating energy from ketones, molecules made in our body when the hormone insulin is low and we are burning relatively higher amounts of fat. The popular "Keto Diet" is named after the process since that low-carb, high-protein diet lowers insulin levels and causes the body to burn fat instead of carbs and produce ketones.

The researchers found widespread glucose metabolism impairment in those nervous system support cells of the brains of former Alzheimer's Disease patients, but limited ketolytic metabolism impairment. The finding is significant because the brain is like a hybrid engine, with the ability to get its fuel from glucose or ketones, but in the Alzheimer's brains studied, there appears to be a fundamental genetic deficit in the brain's ability to use glucose.

"We've turned the hybrid engine of our brains into a mono-fuel system that just fails to thrive," Bikman said. "And so, the brain, which is progressively becoming deficient in its ability to use glucose, is now crying out for help; it's starving in the midst of plenty. The body is swimming in a sea of glucose, but the brain just can't use it.

"The inability to use glucose increases the value of ketones. However, because the average person is eating insulin-spiking foods so frequently, there's never any ketones available to the brain," Bikman added. "I look at these findings as a problem we've created and that we're making worse."

Previous research has observed that the brains of people with AD have a quantifiable reduction in the ability to take in and use glucose, but this paper is the first to show it actually happens at the cellular level. It's a significant contribution to the growing paradigm shift in regards to the scientific view of the causes of Alzheimer's.

And since ketolytic metabolism seems to keep working fine in people with AD, even when glucose metabolism gives out, the paper concludes that treatments involving ketones may be able to support brain metabolism and slow the cognitive decline associated with the disease.

Credit: 
Brigham Young University

Diet + exercise + chemo = increased survival in youth with leukemia

Los Angeles (April 1, 2021) -- Overweight children and adolescents receiving chemotherapy for treatment of leukemia are less successful battling the disease compared to their lean peers. Now, research conducted at the Cancer and Blood Disease Institute at Children's Hospital Los Angeles indicates that modest changes in diet and exercise can greatly increase survival in youth treated for acute lymphoblastic leukemia (ALL), the most common childhood cancer.

"To our knowledge, this is the first study to show that by limiting calories and increasing exercise we can make chemotherapy more effective in eliminating leukemia cells within the first month of therapy, decreasing the chances of disease relapse in children and adolescents," says Principal Investigator Etan Orgel, MD, MS, Director of the Medical Supportive Care Service in the Cancer and Blood Disease Institute at Children's Hospital Los Angeles. The study is published in the American Society of Hematology's journal Blood Advances.

Youth who are obese when they begin chemotherapy are more than twice as likely to have remaining cancer cells after one month of treatment--and an increased chance of disease relapse--compared to their lean counterparts. To address this, the investigators worked with registered dietitians and physical therapists who created personalized diet and exercise plans for 40 patients between the ages of 10 and 21 with newly diagnosed leukemia.

The investigators found that patients who reduced their caloric intake by at least 10% and began a modest exercise regimen beginning at diagnosis were, on average, 70% less likely to have remaining leukemia cells in their bone marrow one month after beginning chemotherapy, compared to previously treated patients who did not participate in the diet and exercise intervention. Remaining leukemia cells, called minimal residual disease, is one of the strongest predictors of poor survival outcomes.

"This is proof of concept that it is possible to increase the effectiveness of chemotherapy without adding other medications and their potential side effects," says Dr. Orgel, who is also an associate professor of clinical pediatrics at the Keck School of Medicine of USC. "This short-term intervention is inexpensive and easily available to providers and families everywhere."

The investigators found that by limiting fat, patients also had decreased insulin resistance as well as increased levels of adiponectin, a metabolic hormone associated with glucose regulation. Identification of these potential biomarkers paves the way to using this intervention to impact other types of cancer.

"Changing diet and exercise made the chemotherapy work better-- that's the big news of this study. But we also need to figure out how," says Steven Mittelman, MD, PhD, Chief of Pediatric Endocrinology at UCLA Mattel Children's Hospital and member of UCLA's Jonsson Comprehensive Cancer Center. "Understanding the biological changes responsible for this effect will help us make these interventions even better." Dr. Mittelman co-led the study and was senior author on the paper.

This clinical trial, called Improving Diet and Exercise in ALL (IDEAL-1), builds on basic and preclinical research conducted for more than a decade at Children's Hospital Los Angeles. This "bench-to-bedside and back" approach provides new insights for treating devastating diseases, like cancer. Physicians observe an unmet clinical need in their patients, collaborate with colleagues in the lab and can then deliver an intervention to the clinic to test its effectiveness.

A randomized trial is planned for later this year. Called IDEAL-2, the study will be conducted by Dr. Orgel and Dr. Mittelman through the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) consortium, headquartered at Children's Hospital Los Angeles under the medical leadership of Alan Wayne, MD, and Deepa Bhojwani, MD.

Credit: 
Children's Hospital Los Angeles

Scientists launch 'herculean' project creating atlas of human genome variants

SEATTLE (April 1, 2021) - An international consortium of geneticists, biologists, clinicians, mathematicians, and other scientists is determined to take the study of the human genome to the next level - creating a comprehensive atlas of genetic variants to advance the understanding, diagnosis, and treatment of disease.

"This Herculean undertaking is unprecedented," said Dr. Matthew Hurles, a geneticist at the Wellcome Sanger Institute in Cambridge, England. "Indeed, the scientific community has an increasingly comprehensive catalog of functional DNA elements in the human genome, but that catalog remains incomplete. We have collectively characterized the functional impact of less than 1% of genetic variation in the 1 to 2 percent of our DNA."

Hurles and Dr. Doug Fowler, a member of the Brotman Baty Institute for Precision Medicine (BBI) and professor of Genome Sciences at the University of Washington's UW Medicine, want to increase those percentages significantly.

They are founding members of the Atlas of Variant Effects (AVE) Alliance and co-authors of a white paper outlining what may be the most ambitious task over the past 30 years since the Human Genome Project.

AVE, along with BBI and the Center for the Multiplexed Assessment of Phenotype, is co-hosting the fourth annual "Mutational Scanning Symposium." The event will bring together global experts performing leading edge research in precision medicine, functional genomics, protein science, and variant interpretation and prediction and will be held virtually for three days beginning on Monday, April 5. Those interested in participating in the free symposium may learn more at https://www.varianteffect.org/aveevents/mutational-scanning-symposium.

The launch of the AVE alliance and the consortium's effort to create the atlas of human genome variants are key issues to be covered at the meeting. The atlas will also examine technology development, data generation, data analysis, data coordination and sharing, and clinical and biological translation.

"We've never known so much about naturally occurring variation in the human genome and now is the time to seize the opportunity to understand what that variation means for human health," said Anna L. Gloyn, DPhil, professor of pediatrics at the Stanford University School of Medicine and an AVE Executive Committee member.

The initial efforts of members of the AVE Alliance will focus on quantifying the functional impact of single nucleotide variants at the genomic loci, primarily human protein-coding genes, that offer the greatest and most immediate clinical utility.

"The ultimate goal is to develop a systematic, extensive understanding of the functional impact of variants in human, model organism and pathogen genomes," Fowler said.

"However, the field of variant effect mapping is already yielding major impacts. We believe and expect that a coordinated and phased approach with others globally could be transformative. The first major, 'real world' impact of the atlas of variant effects is expected to be improved genetic diagnosis and precision medicine."

Credit: 
Brotman Baty Institute for Precision Medicine

Signal detection theory can be used to objectively measure cognitive fatigue

image: Dr. Wylie, the director of the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, conducts research in cognitive fatigue in healthy individuals and populations with multiple sclerosis, brain injury, and Gulf War illness.

Image: 
Kessler Foundation/Jody Banks

East Hanover, NJ. April 1, 2021. A team of New Jersey researchers has shown that changes in perceptual certainty and response bias, two central metrics of signal detection theory (SDT), correlate with changes in cognitive fatigue. They also show that SDT measures change as a function of changes in brain activation. This finding was reported in Frontiers in Psychology on January 15, 2021, in the open access article "Using Signal Detection Theory to Better Understand Cognitive Fatigue" (doi:10.3389/fpsyg.2020.579188).

The authors are Glenn Wylie, DPhil, Brian Yao, PhD, and John DeLuca, PhD, of Kessler Foundation, and Joshua Sandry, PhD, of Montclair State University.

Cognitive fatigue is a common experience that affects the healthy population as well as individuals with brain injury or neurodegenerative disease. A large body of research shows that subjective feelings of cognitive fatigue do not correlate with performance--that is, a person may experience cognitive fatigue and yet objective measures of their performance, such as their response time or level of accuracy, do not necessarily worsen. As a result, researchers have long lacked an objective behavioral measure that covaries with the subjective experience of fatigue.

While previous research has indicated that one metric of SDT, perceptual certainty, may change as a function of fatigue, it remains unclear whether perceptual certainty covaries with fatigue. Moreover, there has been no research investigating the effect of fatigue on the second key SDT metric, response bias, which is the amount of evidence one requires before releasing a response. Understanding if and how cognitive fatigue covaries with both SDT metrics is essential to the development of effective interventions for people with this condition.

The study was conducted at the Rocco Ortenzio Neuroimaging Center at Kessler Foundation, a specialized facility dedicated solely to rehabilitation research. To investigate cognitive fatigue using SDT, the investigators induced cognitive fatigue in 39 healthy volunteers while acquiring both structural and functional magnetic resonance imaging (fMRI) data. They assessed subjects' cognitive fatigue using a visual analogue scale of fatigue (VAS-F) at baseline and after each of the eight runs of the tasks. This enabled the team to assess whether perceptual certainty and response bias covary with cognitive fatigue, and whether similar patterns of brain activation underlie cognitive fatigue and SDT measures.

Researchers found that both SDT metrics were correlated with changes in cognitive fatigue. As fatigue increased, subjects became more conservative in their response bias and their perceptual certainty declined. This study is the first to show that changes in cognitive fatigue are correlated with changes in perceptual certainty.

Furthermore, the research team found that activation in the striatum of the basal ganglia--an area of the brain Kessler researchers have previously identified as sensitive to changes in cognitive fatigue--was also related to response bias and perceptual certainty.

"Our results show that cognitive fatigue is related to changes in subjects' response bias and perceptual certainty," said lead author Dr. Wylie, director of the Ortenzio Center. "We theorize that as cognitive fatigue increases, subjects make more errors because their perceptual sensitivity declines and they compensate for this by adopting a more conservative response bias," he emphasized. "Our work demonstrates the relevance of SDT measures in the understanding of fatigue and provides researchers with a new set of tools with which to better understand the nature and consequences of cognitive fatigue."

Credit: 
Kessler Foundation

Consumers are searching online but not buying. Why?

Key Takeaways:

Discounting or couponing is not the most effective way to tap the power of retargeting in online marketing.

Customized seller recommendations may be more powerful than discounting.

Seller auctions that allow marketers to self-select in the retargeting process improve cost efficiency.

CATONSVILLE, MD, April 1, 2021 - Online marketers have seen the pattern: 95%-98% of online visitors search for something, but the search never converts into a purchase and they leave the site without buying. For marketers, this results in speculation and assumptions that can lead to wasted time and investments in ineffective marketing programs.

One of the more common ways online marketers attempt to solve this problem is to "retarget," which tracks those consumers and reconnects with them at a later point by showing display ads when they browse other websites. You've probably noticed this when using Google Search to find something, such as a pair of shoes, and then later when you're reading a separate news site, you're exposed to a number of display ads centered on that very thing you were searching for earlier.

Once that marketer gets your attention, what can they do to increase the likelihood that you will make a purchase? That question is at the center of a new study that reveals what the best approach to increase conversion rates may be.

The research study to be published in the April issue of the INFORMS journal Marketing Science, "Consumer Search and Purchase: An Empirical Investigation of Retargeting Based on Consumer Online Behaviors," is authored by Zhenling Jiang of The Wharton School at the University of Pennsylvania; Tat Chan of Washington University in St. Louis; Hai Che of the University of California; and Youwei Wang of Fudan University in Shanghai.

To conduct their research, the authors analyzed consumer behaviors in response to two distinct marketing strategies. In one approach, they sent out coupons via those retargeted display ads to be redeemed upon purchasing. In the other approach, the authors used the same display ads to provide seller recommendations that centered on a specific product offering customized to the user, but with no coupon or discount.

"We found that while both strategies help increase the conversion rate, the seller recommendations were more effective than coupons," said Jiang. "This told us that providing consumers with the sellers' information that is most relevant to them may be a more effective way to tap the power of retargeting."

To conduct their research, the authors tapped empirical data from Taobao.com, which is owned by Alibaba, and is the largest online retail platform in China. Like other major e-commerce platforms, it collects consumer browsing history and can reach consumers through direct messaging on the platform, either through the website or its mobile app. The researchers built a consumer search model to establish the relationship between consumer preference and search behaviors. They studied the behavior of 104,189 consumers who searched for a specific product among 20 sellers.

"We noticed some predictable patterns," said Jiang. "Consumers who had a higher search intensity for a specific product were more likely to actually make a purchase. Search intensity was measured in the volume of clicks tied to the same search or search term. What we found was that even where the consumer clicked on multiple possible products, it was the first link they clicked on that had the highest potential of generating a sale. In other words, after a more intense search, the consumer is more likely to go back to that initial seller once a decision to make a purchase is made."

In addition to the two basic retargeting strategies - discounting or customization - the authors proposed to use auction as a pricing mechanism to implement the policies. The auction pricing mechanism requires the seller to self-select. This means the seller selects certain criteria for its ideal customer for a specific product at a specific price point, and then bids on how much it will pay to reach that consumer.

"Through our research, we were also able to show that a pricing mechanism, such as an auction, also tends to improve the effectiveness of a retargeting program," said Jiang. "When Taobao used a pricing mechanism such as an auction, the company was able to improve the efficiency of its retargeting campaigns."

Credit: 
Institute for Operations Research and the Management Sciences

Physicians must advocate for common sense gun laws for good of public health

Below please find a summary of a new article that is published in Annals of Internal Medicine today. The summary is not intended to substitute for the full article as a source of information.

Physicians must advocate for common sense gun laws for good of public health
#thisisourlane
FREE content: https://www.acpjournals.org/doi/10.7326/M21-1505

A pointed editorial by Douglas DeLong, MD, Chief of the Division of General Internal Medicine at Bassett Healthcare in Cooperstown, NY, suggests that it's time for physicians to move past talking and start taking action to protect patients from gun violence and unintentional injury. Dr. DeLong says that in addition to educating patients and their families about firearm safety, physicians must also act locally to stand up against the NRA and advocate for common sense gun laws.

While mass shootings were down overall in 2020, any cause for celebration was short-lived. In March 2021, the U.S. experienced 2 mass shootings taking a total of 18 lives within the span of less than 1 week. The first shooting targeted women and Asian Americans. The motive for the second shooting is not yet known, but the usual "blah, blah, blah" of "thoughts and prayers" was the predictable response from both sides of the political divide.

Dr. DeLong says that now is the time to educate, advocate, and legislate. This means that physicians, given their respected role in society and obligation to promote individual and public health, need to both command their place in the lane (#thisisourlane) and to be at the head of the line with respect to efforts to reduce firearm injury. Dr. DeLong suggests writing letters to editors of local newspapers and to local politicians advocating sensible firearm policy. Physicians can also work with professional societies, such as the American College of Physicians (ACP), which has published several policy papers, position papers, and recommendations on firearm safety, to lobby at all levels for sane firearm injury prevention laws.

Credit: 
American College of Physicians

Significant vaccine distrust found among incarcerated populations, increasing risks

Fewer than half of inmates in jails and prisons surveyed in a study by the CDC and University of Washington said they would accept a COVID-19 vaccine, while the majority either said they wanted to wait before getting the vaccine or would refuse one.

"This is a population already at risk for COVID-19, and outbreaks among incarcerated people can worsen inequities in COVID-19 outcomes as well as contribute to spread in the surrounding community," said lead author Dr. Marc Stern, affiliate assistant professor of health services in the UW School of Public Health. "So culturally and health-literacy informed interventions are needed to help them feel more confident about getting vaccinated."

The study conducted by CDC researchers and led by Stern was published Wednesday on the CDC's Morbidity and Mortality Weekly Report. The researchers surveyed more than 5,000 inmates, men and women, in late 2020 from three prisons and 13 jails in Washington, California, Florida and Texas.

Among those asked about their willingness to receive a vaccine, only 45% said they were willing. More than 45% said they would refuse, and nearly 10% said they might or weren't sure they would receive it.

The most common reasons the participants gave for vaccine hesitancy fell into the response categories of waiting for more information or to see others take it first, and efficacy or safety concerns. The most common reason for given for refusal was distrust of the health care system, correctional or government personnel and institutions.

The survey was conducted before vaccines were available, but at the time Black and younger respondents were the least willing to get the vaccine. The researchers added that a lower willingness to receive a vaccine among Black participants was "not unexpected given historical mistreatment and higher rates of distrust" of these institutions.

"People of color are subject to a 'double whammy' -- they are at higher risk of serious illness from COVID-19 and they are disproportionately incarcerated, living in facilities where they are more likely to become infected," Stern said.

"I hope this study sheds light on the need to find ways of assuring high levels of vaccination of incarcerated individuals," Stern added, "not just for their own health, but for the health of the community. Vaccinating incarcerated individuals not only decreases the risk that officers and other staff will bring COVID-19 home to their family, friends and community, it is also an efficient way to vaccinate a large number of people who are otherwise hard for public health providers to reach once they return to their communities."

Credit: 
University of Washington

Reverse-order heart-liver transplant helps prevent rejection for certain patients

ROCHESTER, Minn. -- All too often, patients with high levels of antibodies face major challenges getting a transplant. These highly sensitized patients have a much higher risk of death while waiting for suitable organs they are less likely to reject. But there is new hope for highly sensitized patients in need of a combined heart and liver transplant, thanks to an innovative surgical approach at Mayo Clinic.

Traditionally, surgeons transplant the heart first, followed by the liver. But Mayo Clinic heart transplant team decided to reverse the order for highly sensitized patients in the hopes that the liver would absorb some of the patient's antibodies, removing them from circulation and lowering the risk of antibody-mediated rejection. The strategy worked, according to a study recently published in the Journal of the American College of Cardiology.

"This unique approach to heart-liver transplant opens the door to more highly sensitized patients getting the transplants they desperately need," says Sudhir Kushwaha, M.D., a Mayo Clinic cardiologist and the study's senior author.

More than 107,000 people in the U.S. are on the waitlist for a lifesaving transplant, according to the Organ Procurement and Transplantation Network. An estimated 20% of people waiting for a transplant are highly sensitized, meaning they have high antibody levels that can cause the immune system to reject a transplanted organ. People can become sensitized due to blood transfusions, pregnancies and previous transplants. April is National Donate Life Month, which encourages people to register to be organ, eye and tissue donors, and honor those who have given the gift of life.

The Mayo Clinic team was inspired to try the heart-after-liver transplant procedure after noting that patients who had undergone a traditional heart-liver transplant were much less likely to experience rejection than those who had a heart transplant alone. Previous research has shown a similar phenomenon for patients undergoing a simultaneous kidney-liver transplant.

Mayo Clinic began offering the pioneering heart-after-liver transplant surgery in 2011. The recently published study reviews the outcomes for seven patients who underwent the procedure. The patients were ages 33-51, and six of the seven were women. All experienced a significant drop in antibodies after the procedure was performed, and none of the patients had experienced rejection within four years following surgery. The study's limitations include its small sample size and younger age of typical transplant patients.

While this new procedure is promising, it comes with major challenges. The heart is usually transplanted first because it is more time-sensitive than other organs. The reverse-order procedure requires a complex choreography between the heart and liver transplant teams to accomplish the procedure.

"Timing is everything. These surgeries require the heart and liver transplant teams to work closely together to limit the time it takes to transplant the donated organs," says Richard Daly, M.D., a Mayo Clinic cardiothoracic surgeon and the paper's first author.

Credit: 
Mayo Clinic

USC Stem Cell study identifies molecular 'switch' that turns precursors into kidney cells

image: From left, Andy McMahon, Lisa Rutledge, Helena Bugacov and Alex Guo hold an impromptu lab meeting.

Image: 
Christina Gandolfo

Kidney development is a balancing act between the self-renewal of stem and progenitor cells to maintain and expand their numbers, and the differentiation of these cells into more specialized cell types. In a new study in the journal eLife from Andy McMahon's laboratory in the Department of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine of USC, former graduate student Alex Quiyu Guo and a team of scientists demonstrate the importance of a molecule called β-catenin in striking this balance.

β-catenin is a key driver at the end of a complex signaling cascade known as the Wnt pathway. Wnt signaling plays critical roles in the embryonic development of multiple organs including the kidneys. By partnering with other Wnt pathway molecules, β-catenin controls the activity of hundreds to thousands of genes within the cell.

The new study builds on the McMahon Lab's previous discovery that Wnt/β-catenin can initiate progenitor cells to execute a lengthy and highly orchestrated program of forming structures in the kidney called nephrons. A healthy human kidney contains a million nephrons that balance body fluids and remove soluble waste products. Too few nephrons results in kidney disease.

Previous studies from the UT Southwestern Medical Center laboratory of Thomas Carroll, a former postdoctoral trainee in the McMahon Lab, suggested that Wnt/β-catenin signaling plays opposing roles in ensuring the proper number of nephrons: promoting progenitor maintenance and self-renewal, and stimulating progenitor cell differentiation.

"It sounded like Wnt/β-catenin is doing two things--both maintenance and differentiation--that seem to be opposite operations," said Guo. "Therefore, the hypothesis was that different levels of Wnt/β-catenin can dictate different fates of the nephron progenitors: when it's low, it works on maintenance; when it's high, it directs differentiation."

In 2015, it became more possible to test this hypothesis when Leif Oxburgh, a scientist at the Rogosin Institute in New York and a co-author of the eLife study, developed a system for growing large numbers of nephron progenitor cells, or NPCs, in a Petri dish.

Relying on this game-changing new system, Guo and his collaborators grew NPCs, added different levels of a chemical that activates β-catenin, and saw their hypothesis play out in the Petri dishes.

They observed that high levels of β-catenin triggered a "switch" in part of the Wnt pathway that relies on another family of transcription factors known as TCF/LEF. There are two types of TCF/LEF transcription factors: one type inhibits genes related to differentiation, and the other activates these genes. In response to high levels of β-catenin, the "activating" members of TCF/LEF switched places with the "inhibiting" members, effectively taking charge. This "switch" triggered NPCs to differentiate into more specialized types of kidney cells.

When they looked at low levels of β-catenin, they saw NPCs self-renewing and maintaining their populations, as expected. However, they were surprised to learn that β-catenin was not engaged with any of the known genes related to self-renewal and maintenance.

"β-catenin does something," said Guo. "That is for sure. But how it does it is kind of mysterious right now."

After publishing these results in eLife, Guo earned his PhD from USC, and began his postdoctoral training at UCLA. Helena Bugacov, a current PhD student in the McMahon Lab and a co-author of the eLife study, is now taking the lead in continuing the project--which has implications far beyond the kidney field, due to the broad role of Wnt throughout the body.

"Understanding how Wnt regulates these two very distinct cell outcomes of self-renewal and differentiation, which is very important for kidney development, is also important for understanding the development of other organs and adult stem cells, as Wnt signaling plays important roles in almost all developmental systems," said Bugacov. "There is also a lot of attention from cancer researchers, as this process can go awry in cancer. Many therapeutics are trying to target this process."

She added, "The more we know about things, the better we can inform work on developing human kidney organoid cultures, which can be more readily used to understand problems in human health, regeneration and development."

Credit: 
Keck School of Medicine of USC

Researchers devise more efficient, enduring CAR gene therapy to combat HIV

FINDINGS

A UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.

This new approach to CAR T gene therapy -- a type of immunotherapy that involves genetically engineering the body's own blood-forming stem cells to create HIV-fighting T cells -- has the potential to not only destroy HIV-infected cells but to create "memory cells" that could provide lifelong protection from infection with the virus that causes AIDS.

BACKGROUND

CAR therapies have emerged as a powerful immunotherapy for various forms of cancer and show promise for treating HIV-1, the more prevalent of the two main forms of the virus. However, current applications of these therapies may not impart long-lasting immunity. Researchers have been seeking a T cell-based therapy that can respond to malignant or infected cells that may reappear months or years after treatment.

In a previous study, the UCLA researchers described the creation of blood-forming stem cells that carry genes for chimeric antigen receptors, or CARs. Once these genetically engineered stem cells are transplanted into the body, they form specialized infection-fighting white blood cells known as CAR T cells that specifically seek out and kill cells infected with HIV.

METHOD

Because HIV binds to CD4 molecules in order to infect cells in the body, the researchers previously created a CAR molecule containing part of the CD4 molecule to hijack that interaction. When HIV would bind to the CD4 section of the CAR molecule on T cells, other regions of the CAR molecule would signal the cell to become activated and kill the virus. That molecule, however, contained two parts, or "domains," that still had the potential to allow HIV infection.

For the new study, the researchers removed those domains while adding another one that makes the cells resistant to infection and allows for a more efficient and longer-lasting cell response against HIV than before.

While the previous approach allowed for the continuous production of new HIV-fighting T cells that persisted for more than two years, these cells were essentially inactivated until they encountered HIV in the body. The improved CAR therapy engineers the body's immune response to HIV rather than waiting for the virus -- or parts of the virus -- to induce a response, in much the same way vaccines prime one's immune system to respond against a virus. The new approach also leads to the production of a significant number of "memory" T cells, that are capable of more potently and quickly responding to reactivated HIV.

IMPACT

The findings provide critical insights into the types of CAR molecules and approaches that are suitable for CAR therapies using blood-forming stem cells and that allow for optimal function and persistence of CAR T cells after development. The findings could influence the field of immunotherapy focused on engineering T cells with CAR molecules that are able to persist and form immunologic memory, and that can recognize and kill virus-infected or cancerous cells.

Credit: 
University of California - Los Angeles Health Sciences

Qubits comprised of holes could be the trick to build faster, larger quantum computers

image: A/Prof Dimi Culcer (UNSW) led the theoretical study

Image: 
FLEET

A new study indicates holes the solution to operational speed/coherence trade-off, potential scaling up of qubits to a mini-quantum computer.

Quantum computers are predicted to be much more powerful and functional than today's 'classical' computers.

One way to make a quantum bit is to use the 'spin' of an electron, which can point either up or down. To make quantum computers as fast and power-efficient as possible we would like to operate them using only electric fields, which are applied using ordinary electrodes.

Although spin does not ordinarily 'talk' to electric fields, in some materials spins can interact with electric fields indirectly, and these are some of the hottest materials currently studied in quantum computing.

The interaction that enables spins to talk to electric fields is called the spin-orbit interaction, and is traced all the way back to Einstein's theory of relativity.

The fear of quantum-computing researchers has been that when this interaction is strong, any gain in operation speed would be offset by a loss in coherence (essentially, how long we can preserve quantum information).

"If electrons start to talk to the electric fields we apply in the lab, this means they are also exposed to unwanted, fluctuating electric fields that exist in any material (generically called `noise') and those electrons' fragile quantum information would be destroyed," says A/Prof Dimi Culcer (UNSW/FLEET), who led the theoretical roadmap study.

"But our study has shown this fear is not justified."

"Our theoretical studies show that a solution is reached by using holes, which can be thought of as the absence of an electron, behaving like positively-charged electrons."

In this way, a quantum bit can be made robust against charge fluctuations stemming from the solid background.

Moreover, the 'sweet spot' at which the qubit is least sensitive to such noise is also the point at which it can be operated the fastest.

"Our study predicts such a point exists in every quantum bit made of holes and provides a set of guidelines for experimentalists to reach these points in their labs," says Dimi.

Reaching these points will facilitate experimental efforts to preserve quantum information for as long as possible. This will also provide strategies for 'scaling up' quantum bits - ie, building an 'array' of bits that would work as a mini-quantum computer.

"This theoretical prediction is of key importance for scaling up quantum processors and first experiments have already been carried out," says Prof Sven Rogge of the Centre for Quantum Computing and Communication Technology (CQC2T)."

"Our recent experiments on hole qubits using acceptors in silicon already demonstrated longer coherence times than we expected," says A/Prof Joe Salfi of the University of British Columbia. "It is encouraging to see that these observations rest on a firm theoretical footing. The prospects for hole qubits are bright indeed."

Credit: 
ARC Centre of Excellence in Future Low-Energy Electronics Technologies

Newly discovered node in brain could expand understanding of dysfunctional social behavior

LA JOLLA, CA--What's the difference between a giggle and a belly laugh? Or a yelp and an all-out scream? In many species, including humans, the volume and duration of a verbal sound conveys as much information as the noise itself.

A group of scientists, led by Scripps Research, has discovered a node in the brains of male mice that modulates the sounds they make in social situations. This discovery, published in Nature, could help identify similar locations in the human brain, and potentially lead to a better understanding of social disorders such as autism or depression.

"Identifying this node gives us signatures of what to look for when human behavior goes awry," says Lisa Stowers, PhD, a neuroscientist and professor at Scripps Research who led the study. "It's giving us clues to how information is organized in the brain, and how different features of information can be separated out in different brain regions."

As part of their courtship behavior, male mice produce "songs." These complicated whistles, which are too high for the human ear to detect, are louder and longer when the female mouse is nearby or when her scent is stronger. The researchers identified a specific type of neuron in a part of the hypothalamus called the lateral preoptic area that controls the emotional regulation of these sounds.

"The hypothalamus and the rest of the limbic system control body functions such as hunger, thirst and temperature regulation, as well as the basic features of emotional behavior like sex and fear," Stowers says. "It is fitting that the emotional aspect of these social noises are generated in this region of the brain."

By directly stimulating the right nodes from these neurons, the scientists could trigger the whole array of noises that go into a mouse song. Varying the level of stimulation allowed them to control how enthusiastic those sounds were.

When the researchers blocked these nodes, male mice encountering a female would attempt to court her in silence. (Female mice responded by kicking the males and running away.) If the researchers bypassed these nodes and activated the next node downstream, the male mice only made long, loud noises.

"They're basically just shouting," Stowers says. "By finding these neurons, it's telling us that this part of the brain is doing this emotional scaling and persistence. If you take that away, then you lose all of that affect, all of that emotional range, and the ability to have effective social communication."

Most research on noise production in the brain has focused on language development, Stowers says. But the sounds that even an infant can make--a giggle, a cry, a scream--don't have to be learned and are just as vital for communication. Identifying how the brain decides on these responses is the first step to understanding where things can go wrong in social behavioral disorders such as autism and depression.

"We are starting to get a detailed look at where in the brain different types of computations are being made," Stowers says. "Now that we know that this simple behavior is regulated in the hypothalamus, we can study whether others behaviors are also using similar circuits and if so, perhaps find a common mechanism--and drug target--for when emotions are not generated appropriately."

Credit: 
Scripps Research Institute

Prioritise opportunities to say final goodbye during COVID-19 pandemic, study finds

First study in bereaved relatives' experience during Covid-19 pandemic lockdown published today

The study makes important recommendations for health and social care professionals providing end-of-life-care

Bereaved families highlighted their need for practical and emotional support when a family member was at end of life

The study found families have increased communication needs when a family member was at end of life, encompassing holistic as well as clinical connections

Phone calls between patients and their relatives should be prioritised during the pandemic to allow loved ones to say goodbye, a new study providing recommendations to healthcare professionals has suggested.

The study, by researchers at the Universities of Sheffield, Oxford and Liverpool is the first of its kind to give a voice to those bereaved during the pandemic. Published today in Palliative Medicine, it explores the impact of restricted visiting to hospitals and care homes due to Covid-19 on relatives' experience of their loved-one's final days, making important recommendations for health and social care professionals to boost the level of care provided.

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life, with many not having seen their relatives for weeks or months due to the pandemic.

Relatives reported relying on connecting virtually with their family members in their final weeks of life, and it seemed these interactions could only happen when they were facilitated by health and social care professionals. There was also a need for more contact highlighted, including holistic as well as clinical communication with healthcare professionals about their loved one's wellbeing and psychological support.

The study makes important recommendations for health and social care professionals providing end-of-life care during a pandemic, finding opportunities must be prioritised for essential connections between families at end-of-life care:

Prioritise connectedness between patients and relatives using video and telephone calls.

Provide relatives with regular telephone updates about personal aspects of care (such as what they had eaten and if they had been able to communicate).

Offer advice and guidance about how to prepare children for the death of a loved one.

Facilitate opportunities for relatives to 'say goodbye' in person before death wherever possible.

The research team says that adopting these recommendations is important as previous research shows when the needs of relatives are addressed at the time a family member is dying, they cope and adjust better in bereavement with improved psychological outcomes and satisfaction with end-of-life care.

During the pandemic, relatives report that they are aware of the multiple demands on health and social care professionals and felt they are 'doing their best given the situation' but identify practical changes that could have made a difference to their experience of bereavement and loss.

Joint Senior Author, Dr Catriona Mayland from the Department of Oncology and Metabolism at the University of Sheffield, said: "Health and social care professionals had very little time to prepare or train for the impact of the pandemic. They faced an increased workload with competing demands and heightened complexity.

"This includes facilitating connectedness between patients and their relatives during the pandemic and they are perceived to be instrumental in this. The study shows the clear need for the opportunity to say goodbye in a meaningful way for families and proactive measures such as protecting time to facilitate connections between patients and relatives will be a valuable way to help families be able to navigate end-of-life care for their loved one and the impact of their grief."

Lead author, Dr Jeff Hanna from the Department of Psychiatry at the University of Oxford, said: "This timely research reports important recommendations for health and social care professionals as they provide end-of-life care during the pandemic. They have a pivotal role in facilitating vital interactions between relatives and their loved ones. The vast number of deaths in the UK means this work provides salient lessons for supporting families at end-of-life."

Dr Stephen Mason, Research and Development Lead for the Palliative Care Unit at the University of Liverpool said: "Our analysis of the experiences of bereaved relatives and health and social care professionals continues, with the hope of providing further insights in how we can maintain and potentially improve care within the limitations of necessary pandemic public health restrictions.

Credit: 
University of Sheffield

Medical studies without adequate pre-publication review could damage public trust in science

The public could lose trust in science if scientific and medical researchers choose to bypass the traditional high standards of peer-reviewed medical journals in the rush to get research data released, particularly during crises such as the COVID-19 pandemic.

That's the warning from three leading medical communications organizations, that have published a joint statement in the peer-reviewed journal Current Medical Research and Opinion - asserting that the integrity of published scientific and medical research must be protected.

Out today, the joint statement from the American Medical Writers Association (AMWA), the European Medical Writers Association (EMWA), and the International Society for Medical Publication Professionals (ISMPP), argues that although peer-review is still the most common process for vetting scientific publications, there is a worrying trend for manuscripts to be released without pre-publication review.

Especially during the COVID-19 health crisis, medical researchers have felt significant pressure to publish COVID-19 findings as quickly as possible, but the statement emphasizes that having a pre-publication review is still essential. The danger is that once the threshold of publication oversight is lowered, it becomes a precedent that cannot be easily reversed, potentially eroding standards and causing the public to lose trust in medical science. "Medical communicators, including writers, editors, and those involved in quality control, play a critical role in ensuring that clinical and scientific data are published and disseminated in an accurate and clear manner. In the current rush-to-publish environment, all stakeholders in the scientific and clinical research communities and press must ensure that the public have correct and actionable information from which to make health and medical decisions," explained Gail Flores, PhD, President of AMWA.

In particular, the statement highlights the impact of preprints - preliminary scientific reports that are made publicly available online for anyone to read and discuss before they have been peer reviewed. While preprints enable rapid release and discussion of data, many are never revised or corrected, and only about a third-to-a half are ever fully published. This can also occur with articles submitted for post-publication peer review, in which an article is published in its original form, before expert peer reviewers are invited to critique it.

The statement recognizes the benefit of rapid publication but alerts that they have to be vetted against the potential harms associated with an accelerated process. "Particularly in these times, it is more important than ever to retain public trust in science, while balancing the need to report timely and relevant medical research," stated Beatrix Doerr, PhD, President of EMWA. In seeking a resolution, the three organizations present recommendations and a Reviewers' Checklist to provide a minimum standard of pre-publication vetting to enhance preprint publication processes.

Their key recommendations include:

Performing more extensive and consistent checks ?  for example, by preprint server hosts  ? - on articles that have not been peer-reviewed prior to publication.

Referencing preprints and articles uploaded for post-publication peer-review only as in-text reference (with a preprint link, DOI, or both), rather than as a bibliographic reference, and clearly labelled as a preprint, or as undergoing post-publication peer review.

Watermarking articles plus including a disclosure within the body of the article highlighting that the findings have not been formally peer-reviewed.

Educating medical journalists and the public about the differences between preprints, post-publication peer review, and traditional peer review.

Crucially, the organizations have also identified ways in which the peer-review process - renowned for being "laborious and time-consuming" - could be expedited. They call upon each stakeholder - authors, journal editors, and publishers - to play a part in this. Their key suggestions include:

Rapid response team of reviewers

Standardized formatting requirements to shorten the time to re-submission

Portable peer-review

Fast-track options

Incentives for reviewers

"For those engaged in preprints, post-publication peer-review, as well as traditional peer-review publications, our joint statement presents key practical recommendations to safeguard the quality of the publications while supporting their more rapid dissemination. We strongly encourage authors, journal editors, publishers, and other stakeholders to review and apply these practical suggestions, ensuring a high-quality standard for published research, irrespective of the format," emphasized Robert J. Matheis, PhD, MA, President and CEO of ISMPP.

Credit: 
Taylor & Francis Group

Pathways leading to the extramedullary development of tissue-resident lymphocytes found

image: Liver ILC1s develop in situ via an interferon-γ-dependent loop during adulthood

Image: 
BAI Lu

Researchers from the University of Science and Technology of China (USTC) of the Chinese Academy of Science (CAS), teamed up with scientists from Aix Marseille University, discovered that hematopoietic progenitors possessed the differentiation potential to type 1 innate lymphoid cells (ILC1s) in adult liver, and dissected the regulation mechanisms of such cell differentiation, revealing the pathways that lead to the development of tissue-resident lymphocytes. This study was published in Science.

Hematopoiesis occurs at different sites following the development of human body. After birth, the bone marrow (BM) has long been known to be the main hematopoietic organ where immune cells develop.

However, a previous study proposed that liver natural killer (NK) cells, retained in the adult liver without circulating through blood out of liver, which distinguished them from conventional NK (cNK) cells. The liver-resident NK cells, also known as liver ILC1s, were then viewed as one of three innate lymphoid cell subsets,.

Expanding studies were subsequently carried out to demonstrate the functional features and differentiation mechanisms of these cells by USTC scientists. Nevertheless, the origin and development of ILC1s remain unclear.

In this study, researchers investigated whether liver-resident ILC1s could develop from local hematopoietic progenitors during adulthood, as BM hematopoiesis was not the major source of them.

By comparing the fetal liver, the adult liver, BM and peripheral blood hematopoietic progenitors, researchers found that adult mouse liver contained Lin?Sca-1+Mac-1+ (LSM) cells, like hematopoietic stem cells (HSCs) in the fetal liver, at significantly higher frequencies. Experiments transferring purified LSM cells from adult liver into sublethally irradiated mice suggested the development potential to multiple hematopoietic lineages, and preferential differentiation into ILC1s in recipient liver through action on local progenitors, of LSM cells.

Moreover, this study revealed the role of interferon-γ (IFN-γ) playing in regulating ILC1s development. The IFN-γ produced by mature liver ILC1s promoted their own development by giving rise to liver LSM cells, while the absence of IFN-γ signaling had a negative effect on expansion of ILC1s rather than cNK cells.

These findings provide evidence for local development of adult liver ILC1s differentiated from fetal liver-derived hematopoietic progenitors, which is positively regulated by self-produced IFN-γ. This study unveils the pathways leading to extramedullary development of innate lymphoid cells, offering explanations of a distinctive regional immune feature within the liver.

Credit: 
University of Science and Technology of China